Associated Papers
Prevalence of germline variants in Brazilian pancreatic carcinoma patients.
Rodrigues LM et al.
Scientific Reports, 2024
Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome.
Chrysafi P et al.
Cancers, 2023
Genetic Predisposition to Numerous Large Ulcerating Basal Cell Carcinomas and Response to Immune Therapy.
Dasgeb B et al.
International Journal of Dermatology and Venereology, 2021
Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention Initiative.
Pearlman R et al.
Jco Precision Oncology, 2021
Identification of MicroRNA-Related Tumorigenesis Variants and Genes in the Cancer Genome Atlas (TCGA) Data.
Li C et al.
Genes, 2020
Collaborative Group of the Americas on Inherited Gastrointestinal Cancer Position statement on multigene panel testing for patients with colorectal cancer and/or polyposis.
Heald B et al.
Familial Cancer, 2020
New Pathogenic Germline Variants in Very Early Onset and Familial Colorectal Cancer Patients.
Djursby M et al.
Frontiers in Genetics, 2020
Diagnostic yield and clinical utility of a comprehensive gene panel for hereditary tumor syndromes.
Henn J et al.
Hereditary Cancer in Clinical Practice, 2019
Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.
Cheng H et al.
Cell Reports, 2018
Evidence for GALNT12 as a moderate penetrance gene for colorectal cancer.
Evans DR et al.
Human Mutation, 2018
Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes.
DeRycke MS et al.
Molecular Genetics & Genomic Medicine, 2017
A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer data.
Melloni GEM et al.
Breast Cancer Research : Bcr, 2017
Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome.
Lorca V et al.
Plos One, 2017
A glycogene mutation map for discovery of diseases of glycosylation.
Hansen L et al.
Glycobiology, 2015
Large numbers of individuals are required to classify and define risk for rare variants in known cancer risk genes.
Shirts BH et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2014
Clinically significant missense variants in human GALNT3, GALNT8, GALNT12, and GALNT13 genes: intriguing in silico findings.
Hussain MRM et al.
Journal of Cellular Biochemistry, 2014
GALNT12 is not a major contributor of familial colorectal cancer type X.
Seguí N et al.
Human Mutation, 2014
Inherited deleterious variants in GALNT12 are associated with CRC susceptibility.
Clarke E et al.
Human Mutation, 2012
Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22.
Gray-McGuire C et al.
Cancer Research, 2010
Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers.
Guda K et al.
Proceedings of the National Academy of Sciences of the United States of America, 2009